| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |